4.7 Article

Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder

期刊

JOURNAL OF NEUROINFLAMMATION
卷 19, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12974-022-02648-y

关键词

Psychosis; Schizophrenia; Bipolar disorder; Major depressive disorder; Affective; Autism; Immune; Cytokine; Inflammation; Neurodevelopmental disorders

资金

  1. National Science Foundation Graduate Research Fellowship
  2. NARSAD young investigator award (PA) [1650042]
  3. National Institute of Child Health and Disease
  4. MIND Institute Intellectual and Developmental Disabilities Research Center [R21HD086669, R01HD090214]
  5. National Institute of Environmental Health Sciences [U54 HD079125]
  6. National Institute of Mental Health [R21ES025560]
  7. [R21MH116383]
  8. [R01MH118209]
  9. [R01MH49883]

向作者/读者索取更多资源

In affective psychosis patients, peripheral blood mononuclear cells (PBMC) produce higher levels of cytokines after stimulation compared to non-affective psychosis patients and healthy controls. These cytokines are associated with both innate and adaptive immune responses. Inflammation may be associated with increased negative symptoms.
Background: Inflammation and increases in inflammatory cytokines are common findings in psychiatric disorders such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD). Meta-analyses of studies that measured circulating cytokines have provided evidence of innate inflammation across all three disorders, with some overlap of inflammatory cytokines such as IL-6 and TNF-alpha. However, differences across disorders were also identified, including increased IL-4 in BD that suggest different immune mechanisms may be involved depending on the type of disorder present. Methods: We sought to identify if the presence or absence of an affective disorder in first-episode psychotic (FEP) patients was associated with variations in cytokine production after stimulation of peripheral blood mononuclear cells (PBMC). 98 participants were recruited and grouped into healthy controls (n = 45) and first-episode psychosis patients (n = 53). Psychosis patients were further grouped by presence (AFF; n = 22) or lack (NON; n = 31) of an affective disorder. We cultured isolated PBMC from all participants for 48 h at 37 & DEG;C under four separate conditions; (1) culture media alone for baseline, or the following three stimulatory conditions: (2) 25 ng/mL lipopolysaccharide (LPS), (3) 10 ng/mL phytohemagglutinin (PHA), and (4) 125 ng/ml alpha-CD3 plus 250 ng/ml alpha-CD28. Supernatants collected at 48 h were analyzed using multiplex Luminex assay to identify differences in cytokine and chemokine production. Results from these assays were then correlated to patient clinical assessments for positive and negative symptoms common to psychotic disorders. Results: We found that PBMC from affective FEP patients produced higher concentrations of cytokines associated with both innate and adaptive immunity after stimulation than non-affective FEP patients and healthy controls. More specifically, the AFF PBMC produced increased tumor necrosis fctor (TNF)-alpha, interleukin (IL)-1 beta, IL-6, and others associated with innate inflammation. PBMC from AFF also produced increased IL-4, IL-17, interferon (IFN)gamma, and other cytokines associated with adaptive immune activation, depending on stimulation. Additionally, inflammatory cytokines that differed at rest and after LPS stimulation correlated with Scale for the Assessment of Negative Symptoms (SANS) scores. Conclusions: Our findings suggest that immune dysfunction in affective psychosis may differ from that of primary psychotic disorders, and inflammation may be associated with increased negative symptoms. These findings could be helpful in determining clinical diagnosis after first psychotic episode.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据